Personalized medicine: risk prediction, targeted therapies and mobile health technology

被引：52

作者：

Hayes, Daniel F. ^{[1
]}

Markus, Hugh S. ^{[2
]}

Leslie, R. David ^{[3
,4
]}

Topol, Eric J.

机构：

[1] Univ Michigan, Ctr Comprehens Canc, Breast Oncol Program, Ann Arbor, MI 48109 USA

[2] Univ Cambridge, Cambridge CB2 1TN, England

[3] St Bartholomews Hosp, London, England

[4] Univ London, Blizard Inst, London WC1E 7HU, England

来源：

BMC MEDICINE | 2014年 / 12卷

关键词：

Diabetes; Genetics; Mobile health; Oncology; Personalized medicine; Smartphone; Stroke; Targeted therapy; GLYCEMIC CONTROL; HYPOGLYCEMIA; ASSOCIATION; METFORMIN; EFFICACY; EVENTS; TRIALS; SAFETY;

D O I：

10.1186/1741-7015-12-37

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Personalized medicine is increasingly being employed across many areas of clinical practice, as genes associated with specific diseases are discovered and targeted therapies are developed. Mobile apps are also beginning to be used in medicine with the aim of providing a personalized approach to disease management. In some areas of medicine, patient-tailored risk prediction and treatment are applied routinely in the clinic, whereas in other fields, more work is required to translate scientific advances into individualized treatment. In this forum article, we asked specialists in oncology, neurology, endocrinology and mobile health technology to discuss where we are in terms of personalized medicine, and address their visions for the future and the challenges that remain in their respective fields.

引用

页数：8

共 19 条

[1] Treatment of HER2-positive breast cancer: current status and future perspectives [J].

Arteaga, Carlos L. ;

Sliwkowski, Mark X. ;

Osborne, C. Kent ;

Perez, Edith A. ;

Puglisi, Fabio ;

Gianni, Luca .

NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (01) :16-32

[2]

Beatson GT., 1896, LANCET, V148, P104

[3] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[4] A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease [J].

Fisman, Enrique Z. ;

Tenenbaum, Alexander .

CARDIOVASCULAR DIABETOLOGY, 2009, 8

[5] Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer [J].

Hassett, Michael J. ;

Silver, Samuel M. ;

Hughes, Melissa E. ;

Blayney, Douglas W. ;

Edge, Stephen B. ;

Herman, James G. ;

Hudis, Clifford A. ;

Marcom, P. Kelly ;

Pettinga, Jane E. ;

Share, David ;

Theriault, Richard ;

Wong, Yu-Ning ;

Vandergrift, Jonathan L. ;

Niland, Joyce C. ;

Weeks, Jane C. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) :2218-2226

[6] Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype Action LADA 7 [J].

Hawa, Mohammed I. ;

Kolb, Hubert ;

Schloot, Nanette ;

Beyan, Huriya ;

Paschou, Stavroula A. ;

Buzzetti, Raffaella ;

Mauricio, Didac ;

De Leiva, Alberto ;

Yderstraede, Knud ;

Beck-Neilsen, Henning ;

Tuomilehto, Jaakko ;

Sarti, Cinzia ;

Thivolet, Charles ;

Hadden, David ;

Hunter, Steven ;

Schernthaner, Guntram ;

Scherbaum, Werner A. ;

Williams, Rhys ;

Brophy, Sinead ;

Pozzilli, Paolo ;

Leslie, Richard David .

DIABETES CARE, 2013, 36 (04) :908-913

[7] Breaking a Vicious Cycle [J].

Hayes, Daniel F. ;

Allen, Jef ;

Compton, Carolyn ;

Gustavsen, Gary ;

Leonard, Debra G. B. ;

McCormack, Robert ;

Newcomer, Lee ;

Pothier, Kristin ;

Ransohof, David ;

Schilsky, Richard L. ;

Sigal, Ellen ;

Taube, Sheila E. ;

Tunis, Sean R. .

SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (196)

[8]

Institute of Medicine Board on Health Sciences Policy Board on Health Care Services Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials, 2012, EVOLUTION TRANSLATIO

[9] Stroke genetics: prospects for personalized medicine [J].

Markus, Hugh S. .

BMC MEDICINE, 2012, 10

[10] Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment A 1-year, randomized, double-blind, placebo-controlled study [J].

McGill, Janet B. ;

Sloan, Lance ;

Newman, Jennifer ;

Patel, Sanjay ;

Sauce, Christophe ;

von Eynatten, Maximilian ;

Woerle, Hans-Juergen .

DIABETES CARE, 2013, 36 (02) :237-244

← 1 2 →